Pulse Biosciences, Inc. Proceeds from Sale and Maturity of Marketable Securities
Pulse Biosciences, Inc. (PLSE) reported Proceeds from Sale and Maturity of Marketable Securities of $4.51 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2022-03-31
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2020-12-31 was -$12.49M.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2020-09-30 was $12.49M.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for fiscal 2020 was $4.51M.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for fiscal 2018 was $24.88M, a 7.46% increase from fiscal 2017.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for fiscal 2017 was $23.15M, a 387.33% increase from fiscal 2016.
- Pulse Biosciences, Inc. proceeds from sale and maturity of marketable securities for fiscal 2016 was $4.75M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$12.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $4.51M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $12.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $17.00M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $4.51M 10-Q · filed 2021-08-09 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $0.00 derived: sum of 2 quarters · filed 2021-03-12 | $0.00 derived: sum of 3 quarters · filed 2021-03-12 | $24.88M 10-K · filed 2021-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $24.88M 10-Q · filed 2019-11-07 | $31.99M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $24.88M 10-Q · filed 2019-08-08 | $31.99M derived: sum of 3 quarters · filed 2019-08-08 | $35.77M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $24.88M 10-Q · filed 2019-05-03 | $31.99M derived: sum of 2 quarters · filed 2019-05-03 | $35.77M derived: sum of 3 quarters · filed 2019-05-03 | $42.22M derived: sum of 4 quarters · filed 2019-05-03 |
| 2017-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $10.90M derived: sum of 2 quarters · filed 2018-03-16 | $17.35M derived: sum of 3 quarters · filed 2018-03-16 | $23.15M 10-K · filed 2018-03-16 |
| 2017-09-30 | $3.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $10.23M derived: sum of 2 quarters · filed 2017-11-08 | $16.03M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $12.25M 10-Q · filed 2017-08-10 | ||
| 2017-03-31 | $5.80M 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $4.75M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |